Efficacy Study of Mindfulness-Based Exercise for Posttraumatic Stress Disorder (PTSD)
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT01462045 |
Recruitment Status :
Completed
First Posted : October 28, 2011
Results First Posted : December 15, 2014
Last Update Posted : January 6, 2015
|
- Study Details
- Tabular View
- Study Results
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Stress Disorders, Post-Traumatic | Behavioral: Mindfulness-based exercise | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 29 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | The Efficacy of Mindfulness-Based Stretching and Breathing Exercise as a Complementary Therapy for Posttraumatic Stress Disorder: A Prospective Randomized Study |
Study Start Date : | October 2011 |
Actual Primary Completion Date : | July 2012 |
Actual Study Completion Date : | October 2012 |

Arm | Intervention/treatment |
---|---|
Experimental: Exercise Group
Participants who are screened positive for PTSD and participate in the series of 16 standardized, semiweekly 60-minute mindfulness-based exercise sessions. The intervention consists of stretching and balancing movements combined with breathing and a focus on mindfulness.Over the course of 8 weeks, the intensity of the exercise increases, but the sequence of the movements is the same.
|
Behavioral: Mindfulness-based exercise
8-week program of mindfulness-based stretching and breathing exercises
Other Name: Mindfulness stretching and breathing exercises |
No Intervention: Control Group
Participants who are screened positive for PTSD but do not participate in the mindfulness-based exercise.
|
|
No Intervention: Base Group
Healthy volunteers who are not screened positive for PTSD and do not participate in the mindfulness-based exercise.
|
- Change From Baseline in PTSD Checklist - Civilian Version (PCL-C) Score [ Time Frame: Baseline and 8 weeks ]The PCL-C is a 17-item self-report instrument that measures the symptoms of PTSD. A total score, ranging from 17 to 85, is found by summing the scores of the 17 items. Higher values are considered to be a worse outcome. The inclusion criteria in the PTSD symptomatic group is a PCL-C total score of at least 28 with a score of 3 or higher on 1 or more items.To detect a reduction in PTSD symptom severity with a 2-sided 5% significance level and a power of 80%, the mean difference of PCL-C scores of 5.16 or greater requires a sample size of 20 participants for Exercise and Control groups, given an anticipated dropout rate of 10%. Data analyses are conducted using an a priori intention-to-treat approach. The analysis for the between-group differences of the intervention is conducted using t-tests comparing Exercise and Control groups at post-intervention. The analysis for the within-group difference is conducted using repeated measures ANOVA for both groups at baseline and week 8.
- Cortisol [ Time Frame: baseline and 8 weeks ]Change from baseline in serum cortisol levels at 8 weeks. Serum cortisol samples were collected at 8:00 Ante Meridian (AM). The changes are calculated from two time points as the values at 8 weeks minus the values at baseline.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 21 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- employed as a nurse
- PCL-C score of at least 28 with at least a score of 3 on one or more items for inclusion in the PTSD symptomatic groups (EX and CON)
- PCL-C score of 27 or lower for inclusion in the non-PTSD symptomatic group (BASE).
Exclusion Criteria:
- the inability to complete the exercise program
- a positive answer to any of the seven screening questions on the Physical Activity Readiness Questionnaire (PAR-Q)
- current use of prednisone or other forms of cortisone medication excluding cortisone in inhaled form

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01462045
United States, New Mexico | |
The University of New Mexico | |
Albuquerque, New Mexico, United States, 87131 |
Principal Investigator: | Mark R Burge, MD | University of New Mexico |
Responsible Party: | University of New Mexico |
ClinicalTrials.gov Identifier: | NCT01462045 |
Other Study ID Numbers: |
CTSC027-2 |
First Posted: | October 28, 2011 Key Record Dates |
Results First Posted: | December 15, 2014 |
Last Update Posted: | January 6, 2015 |
Last Verified: | December 2014 |
Exercise Stress PTSD |
Mindfulness Breathing Cortisol |
Stress Disorders, Traumatic Stress Disorders, Post-Traumatic Trauma and Stressor Related Disorders Mental Disorders |